We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+0.6%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.03B
AUM Growth
+$8.36M
Cap. Flow
+$3.03M
Cap. Flow %
0.3%
Top 10 Hldgs %
69.22%
Holding
164
New
11
Increased
35
Reduced
62
Closed
4
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$658B
$179M 17.43%
1,672,556
+138,636
+9% +$15.1M
EIGI
2
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$115M 11.24%
5,587,577
-461,228
-8% -$9.63M
IEMG icon
3
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$85.4M 8.32%
1,778,141
+96,896
+6% +$4.9M
VEA icon
4
Vanguard FTSE Developed Markets ETF
VEA
$226B
$60.1M 5.85%
1,516,289
-35,502
-2% -$1.47M
IVV icon
5
iShares Core S&P 500 ETF
IVV
$881B
$58.7M 5.71%
283,206
+3,293
+1% +$697K
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$49.6M 4.83%
240,853
-2,527
-1% -$531K
IWB icon
7
iShares Russell 1000 ETF
IWB
$48B
$42M 4.09%
362,374
-10,666
-3% -$1.26M
VV icon
8
Vanguard Large-Cap ETF
VV
$52.2B
$41.5M 4.04%
437,784
-3,671
-0.8% -$355K
VWO icon
9
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$39.7M 3.87%
970,960
-325
-0% -$14K
EFA icon
10
iShares MSCI EAFE ETF
EFA
$76.5B
$39.4M 3.84%
620,336
-20,413
-3% -$1.36M
IJH icon
11
iShares Core S&P Mid-Cap ETF
IJH
$122B
$35.6M 3.46%
1,185,750
-27,040
-2% -$825K
IEFA icon
12
iShares Core MSCI EAFE ETF
IEFA
$186B
$28.7M 2.8%
493,089
+73,495
+18% +$4.47M
VGK icon
13
Vanguard FTSE Europe ETF
VGK
$30B
$28.3M 2.76%
524,896
-3,052
-0.6% -$173K
VIG icon
14
Vanguard Dividend Appreciation ETF
VIG
$111B
$27.2M 2.65%
346,730
-12,969
-4% -$1.05M
IJR icon
15
iShares Core S&P Small-Cap ETF
IJR
$110B
$23.1M 2.25%
391,266
-5,448
-1% -$322K
VPL icon
16
Vanguard FTSE Pacific ETF
VPL
$8B
$17.1M 1.66%
280,008
-2,436
-0.9% -$154K
IWV icon
17
iShares Russell 3000 ETF
IWV
$19.6B
$12.5M 1.22%
100,755
+699
+0.7% +$88K
VO icon
18
Vanguard Mid-Cap ETF
VO
$106B
$10.3M 1%
321,936
-8,320
-3% -$270K
VB icon
19
Vanguard Small-Cap ETF
VB
$79.7B
$7.32M 0.71%
60,221
-94
-0.2% -$11.5K
VEU icon
20
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$7.07M 0.69%
145,595
-248
-0.2% -$12.6K
IWM icon
21
iShares Russell 2000 ETF
IWM
$82.2B
$7.01M 0.68%
56,147
-1,863
-3% -$233K
EEM icon
22
iShares MSCI Emerging Markets ETF
EEM
$28B
$5.16M 0.5%
130,266
AAPL icon
23
Apple
AAPL
$4.89T
$5.13M 0.5%
163,640
-112
-0.1% -$3.58K
GWX icon
24
State Street SPDR S&P International Small Cap ETF
GWX
$856M
$3.81M 0.37%
124,682
-1,435
-1% -$44K
VXF icon
25
Vanguard Extended Market ETF
VXF
$30.5B
$3.64M 0.35%
39,525
-55
-0.1% -$5.11K

Similar funds

Ballentine Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Ballentine Partners held 164 positions worth $1.03B, up 0.82% from $1.02B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Ballentine Partners's Q2 2015 filing shows 11 new, 35 increased, 62 reduced and 4 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 2,509 shares worth $474K. The largest sale was Endurance International Group Holdings, Inc., an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Ballentine Partners's largest Q2 2015 buy was Vanguard S&P 500 ETF: 2,509 shares worth $474K.
  • Ballentine Partners added most to Vanguard Total Stock Market ETF in Q2 2015, an estimated $15.1M increase.
  • Ballentine Partners's biggest Q2 2015 reduction was Endurance International Group Holdings, Inc., cutting an estimated $9.63M.
  • Ballentine Partners fully exited Ocular Therapeutix in Q2 2015, selling an estimated $8.82M.
  • Ballentine Partners's ten largest holdings make up 69% of its $1.03B portfolio in Q2 2015.
  • Ballentine Partners opened 11 new positions and closed 4 in Q2 2015.
  • Ballentine Partners's portfolio value rose 0.82% quarter-over-quarter to $1.03B.

Based on Ballentine Partners's 13F filing for Q2 2015, filed 28 Jul 2015.